Skip to main content

Advertisement

Log in

Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia

  • LETTER TO THE EDITOR
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

No datasets were generated or analysed during the current study.

References

  1. Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stattermayer AF et al (2023) Histological and serological features of acute liver injury after SARS-CoV-2 vaccination. JHEP Rep 5(1):100605

    Article  PubMed  Google Scholar 

  2. Patel AH, Amin R, Lalos AT (2022) Acute liver injury and IgG4-related autoimmune pancreatitis following mRNA-based COVID-19 vaccination. Hepatol Forum 3(3):97–99

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF et al (2022) Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol 77(5):1339–1348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stattermayer A, Cengiz M et al (2022) Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 76(6):1576–1586

    Article  CAS  PubMed  Google Scholar 

  5. Bril F, Al Diffalha S, Dean M, Fettig DM (2021) Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol 75(1):222–224

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kulkarni AV, Anders M, Nazal L, Ridruejo E, Efe C (2023) Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination. J Hepatol 78(2):e60–e61

    Article  CAS  PubMed  Google Scholar 

  7. Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB (2022) Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol 76(1):211–214

    Article  CAS  PubMed  Google Scholar 

  8. Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T et al (2020) A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia. N Engl J Med 382(13):1219–1231

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The Italian Ministry of Health (RC − 2022/2023) supported this work.

Author information

Authors and Affiliations

Authors

Contributions

S.L. collected data, performed research and wrote the original draft. R.B. analysed and interpreted the data and performed review and editing. M.M. performed histological diagnosis. F.G., E.C., A.L.F and M.D.C. performed review, and editing. I.M. critically reviewed and edited the manuscript and supervised the whole work. All authors approved the final manuscript.

Corresponding author

Correspondence to Irene Motta.

Ethics declarations

Informed consent

The patient gave informed consent.

Competing interests

M.D.C. has been or is a current consultant for Celgene Corp (Bristol Myers Squibb) and received research funding from Celgene Corp (Bristol Myers Squibb). I.M. has been or is a current consultant for Bristol Myers Squibb. S.L., R.B., F.G., E.C., M.M., and A.L.F declare no competing financial interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 18.5 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leoni, S., Bou-Fakhredin, R., Granata, F. et al. Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia. Ann Hematol 103, 1025–1026 (2024). https://doi.org/10.1007/s00277-023-05591-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05591-x

Navigation